As the U.S. was scrambling to get its hands on enough Covid-19 rapid antigen tests, it gave a $10.3 million grant to a South Korean biotech company to help develop a new test. Now, the state of Utah has stopped using the test because of how inaccurate it is.
According to an investigation by Judicial Watch, the U.S. Department of Health and Human Services gave the funding to South Korean biotech company GenBody.
Read Full Article »
